Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. (January 2021) - Bertaglia, Valentina
Graphical abstract: Highlights: Survey to evaluate the clinical management of NSCLC patients during the COVID-19 pandemic. Delay of lung cancer diagnosis and a dramatic decrease of patients' accrual within clinical trials. Major changes in the treatment management of elderly population. Major changes in the selection of second line treatments. Telemedicine as a valid support to facilitate patient-healthcare interactions. Abstract: This study investigated the clinical management of non small cell lung cancer (NSCLC) patients during the first wave of coronavirus disease 2019 (COVID-19) outbreak in Italy. A 29-questions survey was sent to 95 Italian thoracic oncologists, with 77 % of them declaring significant changes in the outpatients management and treatment. The results of this survey pointed out a significant delay of lung cancer diagnosis along with a relevant reduction of patients' accrual within clinical trials. Telemedicine emerged as a valid support for patient-healthcare interactions. Therapeutic indications followed the guidelines for adjuvant chemotherapy and concurrent chemo-radiation. Clinical indications to first-line therapies were largely confirmed, while major changes regarded the selection of second line treatment options as well as the management of elderly population. This work may represent a valid source of information to improve the clinical management of NSCLC patients during second wave of COVID-19 pandemic.